Daniel Lee Flynn - Feb 16, 2022 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc. (DCPH)

Role
Chief Scientific Officer
Signature
/s/ Jeffrey M. Held, Attorney-in-Fact
Stock symbol
DCPH
Transactions as of
Feb 16, 2022
Transactions value $
-$12,362
Form type
4
Date filed
2/18/2022, 04:01 PM
Previous filing
Jan 20, 2022
Next filing
Jun 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DCPH Common Stock Sale -$12.4K -1.37K -2.77% $9.05 47.9K Feb 16, 2022 Direct F1
holding DCPH Common Stock 230K Feb 16, 2022 By Daniel L. Flynn Revocable Trust
holding DCPH Common Stock 91K Feb 16, 2022 By Daniel L. Flynn Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was to cover tax liabilities in the vesting of restricted stock.